Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Trans-N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine bis-hydrochloride

EU orphan designation number: EU/3/13/1174   
Active ingredient: Trans-N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine bis-hydrochloride
Indication: Treatment of acute myeloid leukaemia
Sponsor: Oryzon Genomics SA
C. Sant Ferran 74, 08940 Cornella de Llobregat, Barcelona, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
8/08/2013 Orphan designation EMA/OD/064/13 (2013)5273 of 5/08/2013
8/12/2014 Transfer of orphan designation EMA/OD/064/13/T/01 (2014)9378 of 3/12/2014
5/02/2018 Transfer of orphan designation EMA/OD/064/13/T/02 (2018)702 of 1/02/2018